Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 2
1979 4
1980 3
1981 1
1982 2
1983 1
1984 2
1986 3
1988 1
1989 6
1990 6
1991 3
1992 5
1993 8
1994 5
1995 8
1996 12
1997 10
1998 4
1999 4
2000 14
2001 5
2002 5
2003 6
2004 7
2005 13
2006 9
2007 11
2008 14
2009 20
2010 18
2011 14
2012 15
2013 14
2014 10
2015 2
2016 10
2017 7
2018 4
2019 7
2020 2
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. Among authors: lebranchu y. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Free article. Clinical Trial.
What's new in transplantation?
Lebranchu Y. Lebranchu Y. Presse Med. 2022 Dec;51(4):104148. doi: 10.1016/j.lpm.2022.104148. Presse Med. 2022. PMID: 36564130 No abstract available.
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschênes G, Lebranchu Y, Zuber J, Loirat C. Fremeaux-Bacchi V, et al. Among authors: lebranchu y. Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62. doi: 10.2215/CJN.04760512. Epub 2013 Jan 10. Clin J Am Soc Nephrol. 2013. PMID: 23307876 Free PMC article.
New insights into renal transplantation.
Lebranchu Y. Lebranchu Y. Curr Opin Organ Transplant. 2010 Aug;15(4):449-50. doi: 10.1097/MOT.0b013e32833c5396. Curr Opin Organ Transplant. 2010. PMID: 20631614 No abstract available.
mTOR inhibition: the learning curve in kidney transplantation.
Weir MR, Diekmann F, Flechner SM, Lebranchu Y, Mandelbrot DA, Oberbauer R, Kahan BD. Weir MR, et al. Among authors: lebranchu y. Transpl Int. 2010 May 1;23(5):447-60. doi: 10.1111/j.1432-2277.2010.01051.x. Epub 2010 Feb 3. Transpl Int. 2010. PMID: 20136784 Free article. Review.
[Kawasaki disease].
Lebranchu Y. Lebranchu Y. Ann Dermatol Venereol. 1993;120(9):587-8. Ann Dermatol Venereol. 1993. PMID: 8161111 French. No abstract available.
[Allorecognition].
Lebranchu Y. Lebranchu Y. Presse Med. 2001 Sep 1;30(24 Pt 2):31-4. Presse Med. 2001. PMID: 11577585 French.
283 results